Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
20.9M
-
Shares change
-
+248K
-
Total reported value, excl. options
-
$585M
-
Value change
-
+$9.05M
-
Number of buys
-
16
-
Number of sells
-
-15
-
Price
-
$28.00
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2017
37 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2017.
Ascendis Pharma A/S - ADR (ASND) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.9M shares
of 55.6M outstanding shares and own 37.61% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (5.41M shares), FMR LLC (3.24M shares), ORBIMED ADVISORS LLC (2.72M shares), Vivo Capital, LLC (1.77M shares), BAKER BROS. ADVISORS LP (1.35M shares), EcoR1 Capital, LLC (1.03M shares), DEERFIELD MANAGEMENT CO (929K shares), VHCP Management II, LLC (811K shares), venBio Select Advisor LLC (701K shares), and JANUS CAPITAL MANAGEMENT LLC (559K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.